Today, cervical cancer is recognized to be one of the most common types of cancers. It has been analyzed, worldwide; that it is mainly the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for nearly 300,000 deaths annually. According to a recent study, which has been published to the mega-repository of Market Research Hub (MRH), clearly states that the global cervical cancer diagnostic tests market witnessed to acquire uppermost growth over the forecast period due to increasing percentage of HPV infected female population across the globe. This study is titled as "Global Cervical Cancer Diagnostic Tests Market Research Report 2017" which delivers comprehensive information about the market, by analyzing some of the key regions, including North America, China, India, Europe, Southeast Asia and Japan.